About the CPD course
Educational forum in which the advanced breast cancer (BC) clinical community can share their experience of treating hormone receptor positive; human epidermal growth factor receptor-2 negative patients through discussion of a series of relevant patient case studies. The meeting Chair and panel members comprise UK experts in advanced BC. The meeting will also provide an update of recent advances in BC from the European Society for Medical Oncology (ESMO) 2018 meeting.
Send an enquiry
Novartis Pharma UK
Novartis is a healthcare company which strives to change the practice of medicine and aspires to approach things differently. We are passionate about what we do and the impact we have on patients and societies. We are Novartis, and we are re-imagining medicine. Our company comprises three unique divisions: Innovative Medicines, Sandoz and Alcon.
Want to learn more?
More CPD courses by Novartis Pharma UK
Healthcare & Medical
Statistics
Novartis Pharma UK
This course will include training on Survival Time; Censoring; Survival Function; Hazard Function; K...
Training Course
Healthcare & Medical
RESPOND; Risk and Evaluation of SPONDyloarthritis...
Novartis Pharma UK
RESPOND; Risk and Evaluation of SPONDyloarthritis management Spondyloarthritis (SpA) refers to a gro...
Online Course
Get industry-related content straight to your inbox
Thank you for subscribing
By signing up to our site you are agreeing to our privacy policy